Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Fungal re-colonization in cystic fibrosis or bronchiectasis patients after lung transplantation: Incidence, time of onset and related-factors

View through CrossRef
Objectives : In cystic fibrosis (CF) patients, after lung transplantation, the infectious re-colonization remains a major problem. Whilst the outcomes of bacterial re-colonization are well investigated, fungal re-colonization outcomes remains unclear. In this study, we aimed to estimate fungal re-colonization incidence, time of onset and identify related-factors. Methods : We performed a retrospective study of all CF and bronchiectasis patients who undergone lung transplantation between 2000 and 2012 in University Hospital of Bordeaux. Univariate and multivariate analysis were performed in patients who were colonized by fungi before transplantation. Results : Fifty-four patients were included, 45 patients presented fungal colonization. The median follow-up time was 34,9 months during wich 13 patients (24 %) died. Thirty patients (66,7 %) [0,53-0,80] presented fungal re-colonization in post transplantation. Median time of onset in fungal recolonization was of 115 days. In univariate analysis fungal re-colonization was associated with bacterial re-colonization (HR = 0,41), CI 95 % [0,37-1,02] and acute rejection (HR = 0,43), CI 95 % [0,20-0,92]. In multivariate analysis, only acute reject remained associated with fungal re-colonization (HR = 0,43), CI 95 % [0,20-0,93]. Conclusion : Acute allograft rejection episode seems to delay fungal re-colonization, immunosuppressive treatement level of every patients could explain this association. BOS was not associated with fungal re-colonization but the majority of BOS preceded fungal re-colonization. Complementary studies seem necessary to specify fungal re-colonization associated factors.
Title: Fungal re-colonization in cystic fibrosis or bronchiectasis patients after lung transplantation: Incidence, time of onset and related-factors
Description:
Objectives : In cystic fibrosis (CF) patients, after lung transplantation, the infectious re-colonization remains a major problem.
Whilst the outcomes of bacterial re-colonization are well investigated, fungal re-colonization outcomes remains unclear.
In this study, we aimed to estimate fungal re-colonization incidence, time of onset and identify related-factors.
Methods : We performed a retrospective study of all CF and bronchiectasis patients who undergone lung transplantation between 2000 and 2012 in University Hospital of Bordeaux.
Univariate and multivariate analysis were performed in patients who were colonized by fungi before transplantation.
Results : Fifty-four patients were included, 45 patients presented fungal colonization.
The median follow-up time was 34,9 months during wich 13 patients (24 %) died.
Thirty patients (66,7 %) [0,53-0,80] presented fungal re-colonization in post transplantation.
Median time of onset in fungal recolonization was of 115 days.
In univariate analysis fungal re-colonization was associated with bacterial re-colonization (HR = 0,41), CI 95 % [0,37-1,02] and acute rejection (HR = 0,43), CI 95 % [0,20-0,92].
In multivariate analysis, only acute reject remained associated with fungal re-colonization (HR = 0,43), CI 95 % [0,20-0,93].
Conclusion : Acute allograft rejection episode seems to delay fungal re-colonization, immunosuppressive treatement level of every patients could explain this association.
BOS was not associated with fungal re-colonization but the majority of BOS preceded fungal re-colonization.
Complementary studies seem necessary to specify fungal re-colonization associated factors.

Related Results

Lung Transplantation in Cystic Fibrosis Patients: Clinical Presentations and Surgical Considerations
Lung Transplantation in Cystic Fibrosis Patients: Clinical Presentations and Surgical Considerations
Introduction: Lung transplantation has become a critical option for patients with advanced cystic fibrosis, a genetic disorder that causes the production of thick and sticky mucus,...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
The clinical impact of presence and onset time of bronchiectasis on asthmatic patients
The clinical impact of presence and onset time of bronchiectasis on asthmatic patients
Abstract Background: Bronchiectasis is a complex disorder that can arise from asthma and other reasons; patients with asthma an...
Elevated Eosinophil Counts in Acute Exacerbations of Bronchiectasis: Unveiling a Distinct Clinical Phenotype
Elevated Eosinophil Counts in Acute Exacerbations of Bronchiectasis: Unveiling a Distinct Clinical Phenotype
Abstract Background Non-cystic fibrosis bronchiectasis is a chronic respiratory disease characterized by bronchial dilation. However, the significan...
2004 chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians: a comparative study
2004 chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians: a comparative study
AbstractBackgroundChronic respiratory disorders are highly prevalent in Aboriginal Australian population, including chronic obstructive pulmonary disease (COPD) and bronchiectasis....
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

Back to Top